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It is not known if cytokines, which are cell-derived mediators released during the host immune response to stress, aﬀect metabolic
response to stress during critical illness. The aim of this prospective study was to determine whether the metabolic response
to stress is related to the inﬂammatory interleukin-6 (IL-6), 10 (IL-10), and other stress mediators’ responses and to assess
their relationships with diﬀerent feeding patterns, nutritional markers, the severity of illness as assessed by the Multiple Organ
System Failure (MOSF), the Pediatric Risk of Mortality Score (PRISM), systemic inﬂammatory response syndrome (SIRS),
and mortality in critically ill children. Patients were classiﬁed as hypermetabolic, normometabolic, and hypometabolic when
the measured resting energy expenditures (REE) were >110%, 90–110% and, <90% of the predicted basal metabolic rate,
respectively. The initial predominance of the hypometabolic pattern (48.6%) declined within 1week of acute stress (20%), and the
hypermetabolic patterns dominated only after 2 weeks (60%). Only oxygen consumption (VO2) and carbon dioxide production
(VCO2)( P<. 0001) but none of the cytokines and nutritional markers, were independently associated with a hypometabolic
pattern.REEcorrelatedwiththeIL-10butnotPRISM.InthepresenceofSIRSorsepsis,CRP,IL-6,IL-10,PrognosticInﬂammatory
andNutritionalIndex(NI),andtriglycerides—butnotglucose,VO2,orV CO 2 increasedsigniﬁcantly.HighIL-10levels(P = .0000)
andlowmeasuredREE(P = .0000)wereindependentlyassociatedwithmortality(11.7%),whichwashigherinthehypometabolic
compared to other metabolic patterns (P<. 005). Our results showed that only VO2 and VCO2, but not IL-6 or IL-10, were
associatedwithahypometabolicpatternwhichpredominatedtheacutephaseofstress,andwasassociatedwithincreasedmortality.
Although in SIRS or sepsis, the cytokine response was reliably reﬂected by increases in NI and triglycerides, it was diﬀerent from
the metabolic (VO2,V C O 2) or glucose response.
1.Introduction
The relationship between cytokines, acute-phase reactants,
organ failure, and energy expenditure in critically ill children
are poorly understood [1–3]. Interleukin-6 (IL-6) has been
reported to act synergistically with glucocorticoids in stimu-
lating the production of acute-phase reactants [4]. However,
cytokines consist only a part of the deranged metabolism
during stress in children. A number of acute-phase proteins,
such as C-reactive protein (CRP) and ﬁbrinogen, rise after
serious injury or sepsis in association with a drop in
serum albumin, transthyretin, and transferrin. The aims of
this prospective study were to determine the relationship
between inﬂammatory cytokines and other stress media-
tors on the following: (1) measured energy expenditure,
(2) metabolic pattern, (3) nutritional markers, (4) feeding
patterns, (5) severity of illness, and (6) mortality in critically
ill children.
2.MaterialsandMethods
2.1. Patients. A ﬁrst part of this prospective study was
performed in the tertiary care Pediatric Intensive Care Unit
(PICU) at Pittsburgh’s Children Hospital in 1997 when data
were measured and recorded longitudinally (37 patients),
and a second part in the tertiary care PICU at the University2 Clinical and Developmental Immunology
Hospital of Crete between 2006–2008, when only one
measurement was performed per patient (40 patients). First
day results did not diﬀer between the two parts and the
data were pooled for analysis. Repeated measurements were
restricted to the ﬁrst part data. This study was approved by
the Institutional Review Boards, and informed consent was
obtainedfromparents.Allpatientswhowereadmitted tothe
PICUandmechanicallyventilated(MV)foratleast24hours,
were eligible for the study. Patients who were intubated
with cuﬀed endotracheal tubes and those with uncuﬀed
endotracheal tubes without a signiﬁcant air-leak (diﬀerence
between inspired and expired tidal volume <10%) were
included. All patients were ventilated using the Siemens-
Elema Servo 900C ventilator in both PICUs, and all mea-
surementsweredonebythesameinvestigator(GB)usingthe
Deltatrac metabolic monitor. Children with chromosomal
anomalies, dysmorphic syndromes, and severe brain injury,
being evaluated for brain death, were excluded from the
study. Children who required fraction of inspired oxygen
(FIO2) >0.6, use of continuous or bias ﬂow, inspiratory gas
containing gases other than air and oxygen, or who had
chest tubes or a bronchopleural ﬁstula were also excluded.
All patients were hemodynamically stable before the study
period. The physician clinically responsible for the patient
made decisions regarding caloric intake and content entirely
independent of the study.
2.2. Data Collected. Data collected included demographics,
clinical diagnoses, and vital signs. Patients were classiﬁed a
priori into the following diagnostic categories: sepsis, brain
injury, respiratory failure, transplant, and postoperative car-
diac surgery.Sepsis, septic shock, and systemic inﬂammatory
response syndrome (SIRS) were deﬁned using the critieria
developed by the American College of Chest Physicians/
Society of Critical Care Medicine consensus [5]. All patients
with sepsis and septic shock were classiﬁed as the Sepsis
group. The mode of feeding, the nature of nutrition, and
thecaloricintakewerealsorecorded.Childrenwereclassiﬁed
as normal, chronically malnourished, or acutely malnour-
ished. Chronic protein-energy malnutrition (CPEM) and
acute protein-energy malnutrition (APEM) were deﬁned by
the Waterlow’s stages [6]. Anthropometric measurements
included midarm circumference (MAC), cutaneous triceps
skin-fold thickness (TSF), midarm muscle circumference
(MMC), midarm muscle area (MMA), and midarm fat area
(MFA). Fat stores were assessed by measurements of TSF and
MFA, and the somatic protein stores by MMC and MMA.
Fat and protein stores were classiﬁed as normal, nutritionally
at risk, or deﬁcient as deﬁned by Frisancho [7], Ryan and
Martinez [8]. Normal values for weight for length and length
for age were derived from the Standards of the National
Center of Health Statistics [9]. Normal values for TSF, MAC,
MMA, and MFA were derived from the Standards of the
Ten-State Nutritional Survey [10]. The severity of illness was
assessed by the Pediatric Risk of Mortality (PRISM) Score
[11], the Therapeutic Intervention Scoring System (TISS)
modiﬁed for children [12], and indices of organ failure. The
multiple organ dysfunction score (MODS) grades increasing
severity of dysfunction of six organ systems (cardiac, central
nervoussystem,hematologic,hepatic,pulmonary,andrenal)
on a 4-point scale, so that a maximum of 24 points
(100%) can be accrued. The highest scores for each organ
at any point in the hospital course are added to derive the
MODS [13], now recognized as a continuum of physiologic
derangements, rather than an all-or-nothing phenomenon.
The multiple organ system failure (MOSF) (at least two
organ system failures, OSF) was deﬁned using the criteria by
Wilkinson et al. [14].
All patients were studied by indirect calorimetry within
one week of acute stress if they remained mechanically
ventilated. Oxygen consumption (VO2), carbon dioxide
production (VCO2), and the respiratory quotient (RQ),
whichistheVCO2/VO2 ratiousedforthesubstrateoxidation
monitoring,weremeasuredbyindirectcalorimetryusingthe
Deltatrac Metabolic Monitor (SensorMedics) [15, 16]. The
machine was calibrated before each measurement. Resting
Energy Expenditure (REE) was calculated using the Weir
formula modiﬁed by Frayn [17]. Predicted Basal Metabolic
Rate (PBMR) was calculated using the Schoﬁeld equations
[18]. Caloric, protein, fat, and carbohydrate intakes were
calculatedonthesamedayREEwasdetermined.VCO2,V O 2,
REE, PBMR, and caloric intake were indexed to body surface
area.We also calculatedthe ratio ofREE/PBMRto determine
the pattern of energy expenditure. An REE/PBMR ratios of
>1.1, 0.9–1.1, and <0.9 were classiﬁed as hypermetabolic,
normometabolic, and hypometabolic patterns, respectively.
The ratio of caloric intake to REE was also calculated and
ratios of >1.5 and <0.5 were classiﬁed as overfeeding and
underfeeding, respectively.
2.3. Metabolic Markers. Blood samples were drawn on
the same day of the metabolic study. The cytokines IL-
10 and IL-6 were quantitated by commercially available
ELISA technique. The other biochemical markers that were
measured included acute phase reactants such as CRP
and ﬁbrinogen, as well as nutritional markers such as
albumin, prealbumin, and transferrin. To aid interpretation
of sequential measurements with changes in the magnitude
of the acute-phasereaction, a quantitative way of monitoring
the relationship between “nutritional” markers and acute
proteins has been proposed—the Prognostic Inﬂammatory
and Nutritional Index (PINI) [19], deﬁned as PINI = CRP
(mg/L) × a1-acid glycoprotein (mg/L)/Albumin (g/L) ×
Transthyretin (originally called prealbumin) (mg/L). How-
ever, because ﬁbrinogen is more easily done in laboratories,
and because albumin was found to be the worst indicator of
nitrogen balance, we modiﬁed the PINI to the Nutritional
Index (NI), as we had previously described [20]: NI =
CRP (mg/dl) × Fibrinogen (mg/dl)/Transferrin (mg/dl) ×
Transthyretin (mg/dl). Outcome data were PICU Mortality
status, Total hospital stay, PICU length of stay, and Duration
of Mechanical Ventilation.
2.4. Statistical Analysis. Data were initially tested for nor-
mal distribution and homogeneity of variances by the
Kolmogorov-Smirnov statistic with a Lilliefors signiﬁcance
level and the Levene test, respectively. Normally distributed
data are expressed as mean ± SD, while nonnormallyClinical and Developmental Immunology 3
distributed data are given as median and range. Statistical
analysis was performed with a two-tailed t-test for normally
distributed unpaired data after Levene’s correction for
equality of variances or by Mann-Whitney U-Wilcoxon rank
sum W test for nonnormally distributed data. Probability
values of ≤.05 with two-tailed tests were considered signif-
icant. When a linear regression was calculated, Spearman’s
correlation coeﬃcient was employed. Comparisons between
nominal data were made by chi-square Pearson’s statistic
with continuity correction. To determine the strength of
the association between the various metabolic patterns and
mortality the relative risk estimation was measured.
Diﬀerences among various disease groups and among
subcohorts were tested by analysis of variance. Repeated
measurements over time within and between groups were
tested by analysis of variance for repeated measures. Multiple
groupsweretestedbytheone-wayANOVAwiththePostHoc
Student-Newman-Keuls Multiple Range test. Whether the
number of patients and measured variables diﬀered between
groups was tested by contingency table chi square analysis
with continuity correction.
Multivariate stepwise regression analysis was used to
analyze the contribution of the PRISM, MOSF, MODS,
SIRS, classiﬁed sepsis, probability of death values according
to PRISM and MOSF [20] and various clinical factors,
repletedsubstrateandsubstrateutilization,andmalnutrition
or anthropometry values to the variation in the inﬂam-
matory cytokines and other stress mediators. The Hosmer-
Lemeshow Goodness-of-Fit Statistic was used in a logistic
regression analysis model to compare the PRISM and MOSF
probabilities of death to the mortality rate. Associations
between NI or interleukin levels and anthropometry, severity
of illness, clinical, or nutrition risk factor variables were
examined by least squares linear regression for univariate
analysestoidentifyexposurerelatedriskfactorsforincreased
metabolism. Second, a stepwise linear multivariate regres-
sion was used to assess simultaneously the eﬀect of each
variableandtoidentifythosefactorsthatwereindependently
associated with the magnitude of nutritional markers and
stress mediators. Stepwise analysis was done with P<. 1a s
the criterion for eliminating variables (POUT) and P<. 05
as the criterion for retaining variables (PIN). All analyses
weredoneusingtheStatisticalPackagefortheSocialSciences
(SPSS) for Windows (release 17, SPSS, Chicago, IL) software
package.
3. Results
3.1. Characteristics of the Patient Sample. A total of 77
patients were included in the study. The patients ranged
in age from 1 to 210 months (median age 80 months).
The mean length of MV was 6.7 ± 1.2d a y s( r a n g e1
to 30 days), while the mean length of stay in PICU was
10 ± 1.6 days (range 1 to 41 days), and the mean hospital
stay was 24.7 ± 4.3 days (range 3 to 133 days). Eighty-six
percent of patients were Caucasian, with African American
and Hispanics comprising 8% and 5% of the total study
population, respectively. Male/female sex ratio was 57/20.
There was no signiﬁcant air-leak around the endotracheal
tubes (mean diﬀerence between inhaled and exhaled VT was
0.03 ± 0.004%) and all patients were ventilated with a mean
FiO2 0.4 ± 0.01 (range 0.25 to 0.6). The VO2/Body Surface
Area(BSA)andVO2/BSAshowedaveragesof141.5±28(65–
194mL/min/m2) and 125.4 ± 27 (65.2–204mL/min/m2),
respectively. The RQ was 0.89 ± 0.01 (ranged from 0.73 to
1.07), the REE/BSA was 959.9±.01 (385–1435kcal/m2/day),
and the mean of REE/kg was 38.4 (16–63kcal/kg/day).
Fifty one patients (66%) had chronic diseases (cancer 17
patients, end organ failure 16, congenital heart disease or
cardiomyopathy 12, metabolic or other genetic disease 6). Of
all patients, 16 had undergone solid organ transplantation
(20.8%), 12 were cardiac surgical patients (15.6%), 19 had
sepsis (24.7%), 11 respiratory failure (14.3%), 10 metabolic
coma (13.5%), 8 head injury (10.3%), and 1 patient suﬀered
from severe Guillain-Barr´ e syndrome (0.8%). The incidence
of CPEM was 21.6% and the recorded risk for APEM was
8.1%. Regarding the regimens, patients were on at the time
of inclusion in the study, 45.6% were on enteral nutrition,
36.4% on total parenteral nutrition (TPN), 14.3% on
electrolyte and glucose intravenous solutions, and 3.9% on
mixed enteranl parenteral diets. Nine patients died (11.7%),
all with preexisted disease. The ﬁrst day probability of death
according to either PRISM (10.7%) or MOSF (9.7%) did
not diﬀer from the PICU mortality rate (Hosmer-Lemeshow
Goodness-of-Fit Statistic).
3.2. Cytokines, Nutritional Indices, and Severity of Illness.
Bivariatecorrelationsbetweenstressmediatorsornutritional
markers revealed the following.
(1) PRISM was positively correlated to IL-10 (rs = 73,
P<. 000), CRP (rs = 40, P<. 02), and IL-6 (rs = 37,
P<. 05).
(2) TISS was positively correlated with IL-6 (rs = 0.54;
P = .003), IL-10 (rs = 0.68; P<. 001), CRP (rs =
0.52; P = .001), and NI (rs = 0.66; P<. 001) but was
negatively correlated with transthyretin (rs =− 0.49,
P<. 003) and transferrin (rs =− 0.72, P<. 001).
(3) ThemodiﬁedNutritionalIndexcorrelatedwithIL-10
(rs = 0.48, P = .01), IL-6 (rs = 0.50, P = .01), and
PRISM (rs = 0.51, P = .0001).
(4) Signiﬁcant negative correlations between IL-10 and
transferrin (rs =− 0.57, P<. 002) and CRP and
transthyretin (rs =− 0.74, P<. 000) were revealed.
In a multivariate analysis, PRISM was positively cor-
related with high IL-10 levels (r2 = .34, P = .02) and
negatively with transferrin (r2 =− 0.59, P = .0002). When
a multiple linear regression analysis (stepwise method) was
used, classiﬁed sepsis (r2 = 0.25, P = .003), transferrin
(r2 = 0.21, P = .01), IL-6 (r2 = 0.31, P = .002), and the
NI (r2 = 0.52, P = .001) were independently associated with
the PRISM score (F = 12, P = .0000).
3.3. SIRS and Sepsis. Compared to patients with no SIRS,
patientswithSIRShadelevatedCRP(22±15mg/dlversus5±
5mg/dl,P<. 0001),IL-6(1277±1675versus140±77pg/mL,4 Clinical and Developmental Immunology
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Figure 1: Comparison of metabolic monitor measurements,
cytokines, and nutritional markers between patients with and
without systemic inﬂammatory response syndrome (SIRS) (scale
type power: exponent 0.5). In the presence of SIRS signiﬁcantly
increased (∗) were: C-Reactive Protein (CRP), Interleukin-6 (IL-6),
Interleukin-10 (IL-10), nutritional index, and triglycerides (t-test
for unpaired data). Signiﬁcantly decreased (#) despite a higher
protein intake: transferrin and transthyretin. Did not diﬀer com-
pared to the non-SIRS patients: lactate, glucose, ﬁbrinogen, Oxygen
Consumption (VO2), and Resting Energy Expenditure (REE). BSA:
Body Surface Area.
P<. 03), IL-10 (116 ± 129 versus 44 ± 18pg/mL, P<. 05),
NI (11.2 ± 1 3m g / d lv e r s u s2 .3 ± 2.4mg/dl,P<. 02), and
triglycerides (352±4 5 5m g / d lv e r s u s8 1±26mg/dl, P<. 01)
levels. But, transferrin (100 ± 41 versus 171 ± 33mg/dl, P<
.0001) and transthyretin (10±4v e r s u s1 5±6mg/dl,P<. 01)
were lower in the presence of SIRS despite a higher protein
intake (6 ± 4.5v e r s u s3 .3 ± 3g/kg/day ,P<. 005) (Figure 1).
Similar results were observed in septic patients (Figure 2).
Childrenwithsepticshockhadhadsigniﬁcantlyhigherlevels
of IL-6 (2659 ± 2206 versus 475 ± 981pg/mL, P<. 005) and
IL-10 (219 ± 246 versus 63 ± 54pg/mL, P<. 007). Stepwise
regression analysis (F = 12, P = .0002) showed that NI was
positively correlated with SIRS (r2 = .35, P = .007) and IL-6
(r2 = 0.47, P = .01).
3.4. MODS-MOSF. The overall incidence of MOSF was
38.4% and the mean MODS 5 ± 3.4 (66.7% having had
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Figure 2: Comparison of metabolic monitor measurements,
various cytokines, and nutritional markers between patients with
and without sepsis (scale type power: exponent 0.5). Signiﬁcantly
increased (∗) in the presence of sepsis: C-Reactive Protein (CRP),
Interleukin-6 (IL-6), Interleukin-10 (IL-10), nutritional index, and
triglycerides (t-test for unpaired data). Signiﬁcantly decreased (#)
despite a higher protein intake: transferrin and transthyretin. Did
not diﬀer compared to the nonsepsis patients: lactate, glucose,
ﬁbrinogen, Oxygen Consumption (VO2), and Resting Energy
Expenditure (REE). BSA: Body Surface Area.
at least two organs dysfunctioning on a 24 scoring scale),
respectively.BivariatecorrelationsshowedthatbothIL-6and
IL-10 were positively correlated with the MODS (rs = 0.41,
P<. 03, and rs = 0.46, P<. 02, resp.). In the presence
of MOSF (>2 organ failures), CRP (23 ± 16mg/dl versus
7.6 ± 8mg/dl,P<. 001), IL-6 (1394 ± 1686 versus 114 ±
74pg/mL, P<. 02), IL-10 (127 ± 129 versus 39 ± 16pg/mL,
P<. 02), NI (14 ± 14 versus 2.1 ± 2.2, P<. 003), and lactate
(2.4 ± 2.2mg/dl versus 1.1 ± .4mg/dl, P<. 02), but not
glucose, triglycerides, or VCO2/BSA increased signiﬁcantly
compared to the non-MOSF patients, whereas VO2/BSA
(133±32 versus 148±22ml/min/m2, P<. 02), REE (35±12
versus 41 ± 10kcal/kg/day, P<. 03), transferrin (96 ± 36
versus 163 ± 41mg/dl, P<. 0001), and transthyretin (10 ± 4
versus 14 ± 6mg/dl,P<. 02) decreased signiﬁcantly, despite
a higher protein intake (6.4±4.8v e r s u s3 .6±3g/kg/day ,P<
.005) (Figure 3). Sepsis (odd ratio 5.24), among the clinicalClinical and Developmental Immunology 5
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Figure 3: Comparison of metabolic monitor measurements, vari-
ous cytokines, and nutritional markers between patients with and
without multiple organ system failure (MOSF) (scale type power:
exponent 0.5). Signiﬁcantly increased (∗) in the presence of MOSF:
C-Reactive Protein (CRP), Interleukin-6 (IL-6), Interleukin-10
(IL-10), nutritional index, and lactate (t-test for unpaired data).
Signiﬁcantly decreased (#) despite a higher protein intake: Oxygen
Consumption (VO2), Resting Energy Expenditure (REE), transfer-
rin and transthyretin. Did not diﬀer compared to the non-MOSF
patients: triglycerides, glucose, ﬁbrinogen. BSA: Body Surface Area.
variables and IL-10 (odd ratio 1.24, 95% conﬁdence interval
(CI): 0.00–2.19) and transferrin (odd ratio 0.45, CI: 0.00–
6.43) among the stress and nutritional mediators were
independently associated with the development of MOSF
(P<. 0001). Metabolic and feeding patterns did not diﬀer
between patients with or without MOSF.
3.5. Metabolic Patterns. On the ﬁrst day of stress, 48.6% of
children were hypometabolic, 40.5% normometabolic, and
only 10.8% hypermetabolic. In the series of longitudinal
measurements of the 37 patients, the predominance of the
hypometabolic pattern declined within 1 week of acute stress
(20%) and the hypermetabolic pattern only emerged after 2
weeks(60%)(Figure4).Althoughtherewasatrendforlower
levels of cytokines and indices of severity of illness among
hypermetabolic patients (Figure 5), only VO2 and VCO2
were independently associated with a hypometabolic pattern
(P<. 0001).Therewasincreasedincidenceofhypometabolic
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Figure 4: Longitudinal distribution of metabolic patterns in
children during the acute phase of stress. The predominance of
the hypometabolic pattern (50%) declined within 1 week of acute
stress (20%) and the hypermetabolic patterns dominated only after
2 weeks (60%). Paired Resting Energy Expenditure (REE) and
Predicted Basal Metabolic Rate (PBMR) measurements (n = 37).
PICU: Pediatric Intensive Care Unit.
pattern in patients with MOSF (51.7% versus 37.9%) or
septic shock (57.1% versus 35.7%), which however did
not reach statistical signiﬁcance, and increased incidence of
hypermetabolic pattern in patients with APEM (33% versus
16.4%, P<. 004) or muscle stores depletion (66.7% versus
10%, P<. 001). There was no relation between metabolic
patterns and disease groups, SIRS, steroids, blocking agents,
and gender.
3.6. Mortality. Mortality was (a) higher (P<. 05) in
the hypometabolic pattern (22.6%) compared to the hy-
permetabolic (6.7%) or normometabolic (3.2%) patterns
(Figure 6), (b) increased among those receiving partial
or TPN (20% versus 6.4%, P = .07), (c) increased in
patients with NI>10 (50% versus 7.2%, P = .005). Among6 Clinical and Developmental Immunology
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Figure 5: Only Oxygen consumption (VO2) and carbon dioxide
production(VCO2)diﬀeredsigniﬁcantlyamongmetabolicpatterns
(ANOVA, Bonferroni post-hoc tests, P<. 0001). None of the
cytokines and nutritional markers diﬀered between the metabolic
patterns. Note the (nonsigniﬁcant) lower trend of the Pediatric Risk
of Mortality Score (PRISM) and C-Reactive Protein (CRP) values
in the hypermetabolic group of patients. The Box-whisker plots
show the median (horizontal line within the box) and the 10th and
90thpercentiles(whiskers).Theboxlengthistheinterquartilerange
(logarithmic scale). Solid circles represent outliers, stars extremes.
IL-6: Interleukin-6, IL-10: Interleukin-10.
nonsurvivors, CRP (P<. 03), IL-10 (P<. 0001), and NI
(P<. 003) increased signiﬁcantly compared to survivors,
whereas transferrin (P<. 0001) and REE (P<. 02) decreased
signiﬁcantly (Figure 7). In a logistic regression model of
forward stepwise (conditional) analysis, only high IL-10
levels (odd ratio 1.38; CI: 0.00–1.75, P<. 0001) and low
measured REE (odd ratio 0.02; CI: <0.000, P<. 0001) were
independently associated with mortality.
3.7.Cytokines,NutritionalIndices,andFeedingPatterns. Mal-
nourishment (APEM or CPEM), protein depletion (MMA
score 2), and fat depletion (MFA score 2) did not aﬀect
NI values, IL-6 and IL-10 levels. Neither cytokines nor the
NI diﬀered among feeding groups (Figure 8), although RQ
varied at higher levels in the overfeeding (0.91) compared to
the other groups (.88 and .89, resp., P<. 0001). However,
REE, VCO2/BSA, or VO2/BSA did not diﬀer among feeding
groups. REE was only correlated with the IL-10 (r2 =− .48,
P = .01) and white blood cell count (r2 = .36, P = .001), but
not PRISM. The NI was highly increased in the TPN group
(11.8±14) compared to either enteral nutrition alone (1.8±
2.19) or to various dextrose solution regimens (4.46 ± 5.34)
(F = 2.86, P<. 07).
4. Discussion
4.1. Summary of Results. This is the ﬁrst study that has
examined the relationship between cytokines and metabolic
patterns in pediatric patients with critical illness. In the cur-
rent study, in response to stress, stress mediators increased
and nutritional markers decreased proportional to the
degree of illness severity. We further showed that only
VO2 and VCO2 but not IL-6 or 10 were associated with
a hypometabolic pattern which predominated the acute
phase of stress. On the contrary, although in SIRS or sepsis
the cytokine response was reliably reﬂected by increases in
NI and triglycerides, it was diﬀerent from the metabolic
(VO2,V C O 2) or glucose response. In MOSF, the metabolic
work (VO2 and REE), transferrin, and transthyretin decrease
irrespective of the feeding status. We also showed that a
hypometabolicpatternrepresentsanacuteresponsetostress,
is not inﬂuenced by activation of measured cytokines or
feeding status, and is associated with increased mortality.
Finally, our results indicate that the hypometabolic pattern
predominates during the acute phase of stress turning out
into a hypermetabolic pattern during convalescence.
4.2. Cytokines, Metabolism, and Severity of Illness, SIRS,
or Sepsis. The NI used in this study readily reﬂects the
metabolic response to stress in our patients, showing that
priorities in liver synthesis are modiﬁed, with preferential
production of newly synthesized hepatic glycoproteins clas-
siﬁed as acute-phase reactants (such as CRP and ﬁbrinogen)
and inhibition of nutritional markers (such as transferrin
and prealbumin albumin synthesis) [21]. Those changes are
driven by a combination of counterregulatory hormones and
the direct and indirect actions of the various inﬂammatory
mediators, prostaglandin, and kallikreins during the acute
p h a s eo fs t r e s s[ 22]. Recent studies have documented
elevated levels of IL-1 beta, IL-6, IL-7, IL-8, IL-10, IL-13,
and tumour necrosis factor-alpha in septic shock patients
than in those with severe sepsis [23]. In terms of predicting
mortality, the cytokines IL-1 beta, IL-4, IL-6, IL-8, and
granulocyte colony-stimulating factor had good accuracy for
predicting early mortality (< 48 hours), whereas IL-8 and
monocyte chemoattractant protein-1 had the best accuracy
forpredictingmortalityat28days.Ourresultsverifyﬁndings
of a recent study in adult patients in which IL-6 and IL-10
were the key cytokines in the pathogenesis of severe sepsis;
IL-6 was comparatively more associated with septic shock
and IL-10 was comparatively more associated with mortality
[24]. At the time sepsis was ﬁrst suspected in neonates, IL-10
had a sensitivity of 17% and a diagnostic speciﬁcity of 99%
[25]. What we further showed in this study was that not only
interleukins, stress markers, the NI, and also triglycerides are
increased in patients with sepsis and even SIRS, but that they
are also positively correlated to the severity of illness. On the
contrary, we could not verify that glucose, VO2,o rV C O 2Clinical and Developmental Immunology 7
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Figure 6: Mortality was (i) signiﬁcantly higher (Pearson chi-square, asymptomatic signiﬁcance 2-sided P<. 05) in the hypometabolic
pattern (22.6%) compared to the hypermetabolic (6.7%) or normometabolic patterns (3.2%), (ii) exclusively restricted to patients with
Pediatric Risk of Mortality Score (PRISM)>10 (25.7% versus 0, P<. 0001), and (iii) increased among those receiving partial or Total
Parenteral Nutrition (TPN) (20% versus 6.4%, P = .7).
increase in the presence of SIRS and sepsis [26] in our non-
diabetic population [27], but that only nutritional markers
decrease signiﬁcantly.
4.3. Cytokines, Metabolism, and MOSF. Previous studies
showed that IL-6 and IL-8 concentrations during the ﬁrst 24
hours were predictive of worsening organ dysfunction [3]o r
failure of organ dysfunction to improve on day three [23].
Because cytokines are inﬂuenced by a multitude of other
factorsoccurringintheintensivecaresetting,[28,29]r egr es-
sion analysis was done to ﬁnd out factors independently
associated with a speciﬁc cytokine induction or signiﬁcantly
inﬂuencingthedevelopmentofMOSF.Inourstudy,IL-6and
10, the NI, and lactate increased with MOSF and nutritional
indices decreased, but only sepsis and IL-10 among the
stress mediators were independently associated with the
development of MOSF. This antiinﬂammatory approach to
MOSF along with the absence of an independent association8 Clinical and Developmental Immunology
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Figure 7: Opposite trends of C-Reactive Protein (CRP), Inter-
leukin-10 (IL-10), and nutritional index compared to transferrin,
and Resting Energy Expenditure (REE) were recorded between
survivors and non-survivors.
with the proinﬂammatory IL-6 might be explained by an
immediate hyperactivation of circulating monocytes, which
might be rapidly followed by a substantial paralysis of cell
function [30]. Although it has been previously shown that
admission IL-10 is related to the severity of organ failure and
mortality in children with septic shock [31], our results for
the ﬁrst time demonstrate that metabolism, as expressed by
measured VO2 and REE, is down-regulated in patients with
MOSF (Medline search).
4.4. Metabolic Patterns and MOSF. An important ﬁnding of
this study is that the predominant metabolic pattern during
theacutephaseofcriticalillnessisthehypometabolic(halfof
patients), whereas the hypermetabolic pattern only emerges
during convalescence. Simultaneously, the most important
factor that was leading to a hypometabolic response was
MOSF or septic shock and, if persisted, impeding death
(mortality). Previous studies have also demonstrated that
children do not become hypermetabolic during critical
illness [32] and that energy expenditure is close to or
even lower than predicted basal metabolic rate [33]. The
hypometabolic response may therefore reﬂect failure of
the neurohumoral system to servoregulate the metabolic
machinery,resultinginfailureofenergyproduction,reduced
tissue substrate utilization and VO2 anaerobic metabolism
and lactic acidosis, and ultimately organ failure. Growing
evidence suggests that mitochondrial inhibition plays a
major role in the development of multiple organ failure
during sepsis [34]. Once mitochondrial dysfunction has
developed, the regulated induction of a hypometabolic state,
analogous to hibernation, may protect the cells from severe
bioenergetic failure and a critical fall in ATP. Though
this is clinically manifest as organ dysfunction, it may
actually represent an adaptive response to a prolonged,
severe inﬂammatory stress [34]. These changes suggest a
progressivefailureofenergyproduction,probablyatthelevel
ofthemitochondria, resultingin reducedtissueoxygenation,
decreased substrate utilization, and ultimately MOSF and
death. This hypothesis is further supported by ﬁndings of
this study, which have shown a signiﬁcant relationship of
MOSF to the NI followed by depressed VO2 and nutritional
markers.
4.5. Metabolic Patterns and Feeding Status. Our MOSF or
SIRS patients were receiving higher amounts of protein
compared to the non-MOSF or non-SIRS patients, so that
we were unable to assess the contribution of relative protein
depletion to the organ nutrition derangement. Thus, food
restriction, where all essential nutrients were reduced in
proportion, was a physiologic stress that, while limiting
growth,didnotactivateorimpairthesystemicinﬂammatory
response, whereas a very low protein diet with little change
in energy intake had a substantial impact on systemic
inﬂammation, body composition, and growth [35].
It has been previously shown that caloric restriction
inhibits up-regulation of inﬂammatory cytokines and TNF-
alpha, and activates IL-10 and haptoglobin in the plasma of
streptozotocin-induced diabetic rats [36]. Although it has
been also shown that the expression levels of IL-10 were
higher and IL-6 genes were expressed less in malnourished
noncritically ill children [37], we did not ﬁnd that malnour-
ishment or severe substrate depletion aﬀected key cytokines
reaction or metabolism. We had also previously shown that
patients at risk for protein stores depletion had a higher
incidenceofMOSF,whereaspatientswithfatstoresdepletion
had a higher probability of death, when compared with
nutritionally normal children [33].
In this study, we showed an increased incidence of
hypermetabolic pattern in patients with APEM or muscle
stores depletion, an indicative of the severe hyper-catabolic
state in which these groups of patients are. In addition,
although metabolic patterns were not related to speciﬁc
feeding patterns, overfed patients had signiﬁcantly higher
RQ,supportingRQusefulnesstoidentifyingoverfeedingand
excluding underfeeding [38].
4.6. Cytokines, Metabolism and Nutritional Interventions.
Regarding fats, high-density lipoproteins have been shown
to bind and neutralize lipopolysaccharide and are regarded
as possible therapeutic agents for sepsis and conditions asso-
ciated with local or systemic inﬂammation [39]. However,
in recent years, a multitude of possible immunomodula-
tory properties other than lipopolysaccharide neutralization
have become evident [40]. Thus, under stress conditions,
glutamine availability can become rate limiting for key cell
functions, such as phagocytosis and antibody production
[41]. In addition, the reprioritization of the liver synthetic
pathways and the increased catabolism of certain of these
proteins make them much more an indicator of severe illness
than a measure of the liver’s synthetic ability [42, 43]. In ill
patients, like those in our study, plasma concentrations of
visceral proteins tend to be lowered and return to normal as
the disease process itself recovers [44]. By day 5, nutritionalClinical and Developmental Immunology 9
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Figure 8: (a) Only the respiratory quotient (RQ) varied at higher levels in the overfeeding compared to the other groups (ANOVA,
Bonferroni post-hoc tests, P<. 0001); (b) Nutritional and stress indices did not diﬀer among feeding groups during the acute phase of stress.
The Box-whisker plots show the median (horizontal line within the box), and the 10th and 90th percentiles (whiskers). The box length is
the interquartile range (logarithmic scale). Solid circles represent outliers. REE: Resting Energy Expenditure, VO2: Oxygen Consumption,
VCO2: Carbon Dioxide production, BSA: Body Surface Area, IL-6: Interleukin-6, IL-10: Interleukin-10.
indices and antioxidant catalysts showed a higher increasing
trend in an immune-enhancing formula compared with
conventional early enteral nutrition [45]. However, we did
notuseanyimmune-enhancingformulainthepresentstudy.
The highest mortality in the partial or TPN group might
be related to the worst severity of disease, as evidenced by
a PRISM>10, and to the worst inﬂammation, as evidenced
by an NI>10 among these patients. However, our data
also suggested that parenteral nutrition might be associated
with a worse eﬀect on metabolism than enteral nutrition.
Recent work has shown that up-regulation of Toll-like
receptors in intestine in response to TPN administration
and a lack of enteral nutrition may be associated with an
increased risk of septic shock due to bacterial translocation
caused by a signiﬁcant decline in intestinal intraepithelial
lymphocyte-derived IL-10 expression, a cytokine that has
beenshowninvitrotomaintaintightjunctionintegrity[46],
and by interferon gamma-mediated intestinal epithelial cell
apoptosis [47]. Comparing the eﬀects of early randomized
immune or nonimmune-enhancing enteral nutrition on
cytokine production in children with septic shock, we
had previously showed that IL-6 levels were signiﬁcantly
lower in the immune-enhancing than in the non-immune-
enhancing group [48]. Similarly, in a multivariate regression
analysis among children with severe head injury, we had
showed that IL-8 was independently negatively correlated
with immunonutrition [43].
4.7. Limitations. The main limitation of the study is that
it only examined the acute phase of the critical illness in
an intensive care setting. More extended studies are needed
in children and adults or various subcohorts [49] to assess
metabolic patterns related to cytokine reactions at diﬀerent
time points in their illnesses. An indication of such a need
might be the longitudinal series we performed that produced
ad i ﬀerent metabolic pattern during the acute stress phase
compared to a presumed (2nd week) convalescent phase of
the illness. Although we did not attempt to control variables
such as diagnosis, severity of illness, type of patients, or the
care provided during the study, we entered all these variables
in multiple regression and logistic analyses of our data. It is
diﬃcult to determine with accuracy, however, whether these
factors aﬀected our results.
5. Conclusions
In summary, more than half of the patients had energy
expenditure more than 10% above or below predicted values
and an associated increased risk of mortality during an
acute illness. In the current study, in response to stress,
interleukins and stress mediators increased and nutritional
markers decreased proportional to the degree of illness
severityanddevelopmentofSIRS,sepsis,orMOSF.However,
onlyVO2 andVCO2 butnotIL-6or10wereassociatedwitha
hypometabolic pattern which predominated the acute phase10 Clinical and Developmental Immunology
of stress. On the contrary, although in SIRS or sepsis the
cytokine response was reliably reﬂected by increases in NI
and triglycerides, it was diﬀerent from the metabolic (VO2,
VCO2) or glucose response. A metabolic work (VO2 and
REE) derangement, like the hypometabolic pattern recorded
in MOSF, developed irrespective of the feeding status, was
not inﬂuenced by activation of measured cytokines, and had
a worse outcome. Since diﬀerent metabolic patterns might
be interchanging during a clinical course of severe illness,
a systemic followup of metabolism might improve early
diagnosis and contribute to an optimal therapeutic support.
Further research to address possible pharmaconutritional
interventions in the various phases of the metabolic response
to stress should be carefully planned.
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